Los Angeles Capital Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.6K | Buy |
+13,465
| New | +$92.6K | ﹤0.01% | 1257 |
|
|
2024
Q3 | – | Sell |
-21,038
| Closed | -$130K | – | 1213 |
|
|
2024
Q2 | $130K | Buy |
+21,038
| New | +$130K | ﹤0.01% | 1149 |
|
|
2021
Q1 | – | Sell |
-20,757
| Closed | -$243K | – | 1605 |
|
|
2020
Q4 | $243K | Sell |
20,757
-10,713
| -34% | -$125K | ﹤0.01% | 1437 |
|
|
2020
Q3 | $250K | Buy |
31,470
+15,891
| +102% | +$126K | ﹤0.01% | 1327 |
|
|
2020
Q2 | $285K | Buy |
15,579
+4,950
| +47% | +$90.6K | ﹤0.01% | 1298 |
|
|
2020
Q1 | $127K | Buy |
+10,629
| New | +$127K | ﹤0.01% | 1269 |
|